GSE53960: rat RNA-Seq transcriptomic Bodymap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Zfp384
|
ENSRNOG00000017066 | zinc finger protein 384 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Zfp384 | rn6_v1_chr4_+_157523320_157523320 | 0.65 | 4.2e-40 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr11_+_86094567 | 41.62 |
ENSRNOT00000086514
|
LOC100361706
|
lambda-chain C1-region-like |
chr2_+_223029559 | 25.84 |
ENSRNOT00000045584
|
AABR07013111.1
|
|
chr4_+_69457472 | 25.05 |
ENSRNOT00000067597
|
Trbv19
|
T cell receptor beta, variable 19 |
chr6_-_138632159 | 23.46 |
ENSRNOT00000082921
ENSRNOT00000040702 |
Ighm
|
immunoglobulin heavy constant mu |
chr17_+_43423111 | 22.94 |
ENSRNOT00000022630
|
Hist1h2ba
|
histone cluster 1 H2B family member a |
chr17_+_43734461 | 21.57 |
ENSRNOT00000072564
|
Hist1h1d
|
histone cluster 1, H1d |
chr17_-_43422846 | 21.07 |
ENSRNOT00000050526
|
Hist1h2aa
|
histone cluster 1 H2A family member a |
chr17_-_44748188 | 20.99 |
ENSRNOT00000081970
|
LOC103690190
|
histone H2A type 1-E |
chr1_-_16687817 | 20.93 |
ENSRNOT00000091376
ENSRNOT00000081620 |
Myb
|
MYB proto-oncogene, transcription factor |
chr17_+_44760056 | 20.89 |
ENSRNOT00000052073
|
LOC690171
|
similar to H3 histone, family 3B |
chr17_+_44763598 | 20.84 |
ENSRNOT00000079880
|
Hist1h3b
|
histone cluster 1, H3b |
chr17_-_43807540 | 20.34 |
ENSRNOT00000074763
|
LOC684762
|
similar to CG31613-PA |
chr10_-_89452200 | 20.13 |
ENSRNOT00000083111
|
Brca1
|
BRCA1, DNA repair associated |
chr17_-_43776460 | 19.27 |
ENSRNOT00000089055
|
Hist2h3c2
|
histone cluster 2, H3c2 |
chr17_-_43798383 | 19.23 |
ENSRNOT00000075069
|
LOC684828
|
similar to Histone H1.2 (H1 VAR.1) (H1c) |
chr3_+_17546566 | 18.92 |
ENSRNOT00000050825
|
AABR07051583.1
|
|
chr11_+_86092468 | 18.88 |
ENSRNOT00000057971
|
LOC100361706
|
lambda-chain C1-region-like |
chr9_-_84894599 | 18.77 |
ENSRNOT00000018423
|
Hdac1l
|
histone deacetylase 1-like |
chr17_+_43633675 | 18.50 |
ENSRNOT00000072119
|
LOC102549173
|
histone H3.2-like |
chr3_+_19128400 | 18.39 |
ENSRNOT00000074272
|
AABR07051673.1
|
|
chr17_-_44793927 | 18.25 |
ENSRNOT00000086309
|
Hist1h2bo
|
histone cluster 1 H2B family member o |
chr4_+_70572942 | 18.03 |
ENSRNOT00000051964
|
AC142181.1
|
|
chr4_+_98370797 | 17.13 |
ENSRNOT00000031991
|
AABR07060872.1
|
|
chr4_+_101645731 | 16.99 |
ENSRNOT00000087901
|
AABR07060953.1
|
|
chr15_+_42489377 | 16.93 |
ENSRNOT00000064306
|
Pbk
|
PDZ binding kinase |
chrX_-_123662350 | 16.68 |
ENSRNOT00000092624
|
Sept6
|
septin 6 |
chr16_+_90613870 | 15.44 |
ENSRNOT00000079334
|
Shcbp1
|
SHC binding and spindle associated 1 |
chr17_-_44758170 | 15.20 |
ENSRNOT00000091176
|
Hist1h2bo
|
histone cluster 1 H2B family member o |
chr3_+_17889972 | 15.02 |
ENSRNOT00000073021
|
AABR07051611.1
|
|
chr3_+_141577504 | 14.90 |
ENSRNOT00000067983
|
Pax1
|
paired box 1 |
chr13_+_51795867 | 14.87 |
ENSRNOT00000006747
|
Ube2t
|
ubiquitin-conjugating enzyme E2T |
chr17_-_44834305 | 14.80 |
ENSRNOT00000084303
|
Hist1h2bd
|
histone cluster 1, H2bd |
chr1_-_198476476 | 14.45 |
ENSRNOT00000027525
|
Kif22
|
kinesin family member 22 |
chrX_+_78196300 | 14.10 |
ENSRNOT00000048695
|
P2ry10
|
purinergic receptor P2Y10 |
chrX_+_138046494 | 14.05 |
ENSRNOT00000010596
|
Stk26
|
serine/threonine kinase 26 |
chr17_+_44758460 | 14.03 |
ENSRNOT00000089436
|
Hist1h2an
|
histone cluster 1, H2an |
chr15_+_61826937 | 14.00 |
ENSRNOT00000084005
ENSRNOT00000079417 |
Elf1
|
E74-like factor 1 |
chr17_+_44738643 | 13.96 |
ENSRNOT00000087643
|
LOC100910554
|
histone H2A type 1-like |
chr4_+_99185885 | 13.89 |
ENSRNOT00000009392
|
Cd8b
|
CD8b molecule |
chr15_-_24199341 | 13.66 |
ENSRNOT00000015553
|
Dlgap5
|
DLG associated protein 5 |
chr6_-_140102325 | 13.64 |
ENSRNOT00000072238
|
AABR07065750.2
|
|
chr6_-_139719323 | 13.48 |
ENSRNOT00000090133
|
AABR07065705.4
|
|
chr15_+_61826711 | 13.28 |
ENSRNOT00000068269
|
Elf1
|
E74-like factor 1 |
chr14_-_69927938 | 12.69 |
ENSRNOT00000058838
|
Ncapg
|
non-SMC condensin I complex, subunit G |
chr3_+_20641664 | 12.49 |
ENSRNOT00000044699
|
AABR07051741.1
|
|
chr2_-_200762492 | 12.49 |
ENSRNOT00000056172
|
Hsd3b2
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 |
chr4_+_56337695 | 12.46 |
ENSRNOT00000071926
|
Lep
|
leptin |
chr17_-_43614844 | 12.39 |
ENSRNOT00000023054
|
Hist1h1a
|
histone cluster 1 H1 family member a |
chr13_+_83996080 | 12.38 |
ENSRNOT00000004403
ENSRNOT00000070958 |
Cd247
|
Cd247 molecule |
chr13_-_45318822 | 12.21 |
ENSRNOT00000091514
ENSRNOT00000005143 |
Cxcr4
|
C-X-C motif chemokine receptor 4 |
chr15_-_29246222 | 12.20 |
ENSRNOT00000081806
|
AABR07017617.1
|
|
chr17_-_44841382 | 12.12 |
ENSRNOT00000080119
|
Hist1h2ak
|
histone cluster 1, H2ak |
chr3_+_19174027 | 11.94 |
ENSRNOT00000074445
|
AABR07051678.1
|
|
chr17_+_44794130 | 11.86 |
ENSRNOT00000077571
|
Hist1h2ac
|
histone cluster 1, H2ac |
chr17_+_43632397 | 11.68 |
ENSRNOT00000013790
|
Hist1h2ah
|
histone cluster 1, H2ah |
chr6_-_138508753 | 11.48 |
ENSRNOT00000006888
|
Ighm
|
immunoglobulin heavy constant mu |
chr8_-_39830306 | 11.43 |
ENSRNOT00000040901
|
Ccdc15
|
coiled-coil domain containing 15 |
chr10_+_106856097 | 11.43 |
ENSRNOT00000072387
|
Birc5
|
baculoviral IAP repeat-containing 5 |
chr9_+_23354770 | 11.38 |
ENSRNOT00000081459
|
Cenpq
|
centromere protein Q |
chr2_+_231884337 | 11.30 |
ENSRNOT00000014695
|
Zgrf1
|
zinc finger, GRF-type containing 1 |
chr5_-_118541928 | 11.28 |
ENSRNOT00000012947
|
Itgb3bp
|
integrin subunit beta 3 binding protein |
chr7_+_140758615 | 11.21 |
ENSRNOT00000089448
|
Troap
|
trophinin associated protein |
chr15_+_87886783 | 11.17 |
ENSRNOT00000065710
|
Slain1
|
SLAIN motif family, member 1 |
chr16_-_31301880 | 11.10 |
ENSRNOT00000084847
ENSRNOT00000083943 |
AABR07025272.1
|
|
chr2_+_26240385 | 10.91 |
ENSRNOT00000024292
|
F2rl2
|
coagulation factor II (thrombin) receptor-like 2 |
chr9_-_53118613 | 10.86 |
ENSRNOT00000065581
|
Ormdl1
|
ORMDL sphingolipid biosynthesis regulator 1 |
chr6_+_139486775 | 10.81 |
ENSRNOT00000077771
|
AABR07065699.3
|
|
chr1_-_198128857 | 10.81 |
ENSRNOT00000026496
|
Coro1a
|
coronin 1A |
chr12_-_38274036 | 10.79 |
ENSRNOT00000063990
|
Kntc1
|
kinetochore associated 1 |
chr6_-_138550576 | 10.71 |
ENSRNOT00000075284
|
AABR07065645.1
|
|
chr4_-_170763916 | 10.68 |
ENSRNOT00000071512
|
Hist1h4m
|
histone cluster 1, H4m |
chr1_-_197821936 | 10.58 |
ENSRNOT00000055027
|
Cd19
|
CD19 molecule |
chr3_+_20375699 | 10.55 |
ENSRNOT00000088492
|
AABR07051731.1
|
|
chr6_-_86924146 | 10.55 |
ENSRNOT00000029411
|
Mis18bp1
|
MIS18 binding protein 1 |
chr9_-_26932201 | 10.54 |
ENSRNOT00000017081
|
Mcm3
|
minichromosome maintenance complex component 3 |
chr4_-_170092848 | 10.53 |
ENSRNOT00000072147
|
Hist2h4
|
histone cluster 2, H4 |
chr15_-_29443454 | 10.41 |
ENSRNOT00000082167
|
AABR07017635.2
|
|
chrX_-_123601100 | 10.33 |
ENSRNOT00000092546
ENSRNOT00000092301 |
Sept6
|
septin 6 |
chr2_+_52333396 | 10.24 |
ENSRNOT00000046174
|
RGD1306227
|
similar to 4833420G17Rik protein |
chr16_+_7212488 | 10.23 |
ENSRNOT00000024840
|
Nt5dc2
|
5'-nucleotidase domain containing 2 |
chr13_-_91981432 | 10.19 |
ENSRNOT00000004637
|
AABR07021804.1
|
|
chr17_-_43640387 | 10.18 |
ENSRNOT00000087731
|
Hist1h1c
|
histone cluster 1 H1 family member c |
chr3_-_67668772 | 10.13 |
ENSRNOT00000010247
|
Frzb
|
frizzled-related protein |
chr10_-_45297385 | 10.10 |
ENSRNOT00000041187
|
Hist3h2bb
|
histone cluster 3 H2B family member b |
chr2_+_187218851 | 9.96 |
ENSRNOT00000017798
|
Sh2d2a
|
SH2 domain containing 2A |
chr20_+_20577561 | 9.93 |
ENSRNOT00000081113
|
Cdk1
|
cyclin-dependent kinase 1 |
chr17_+_44748482 | 9.91 |
ENSRNOT00000083765
|
Hist1h2bl
|
histone cluster 1 H2B family member l |
chr6_-_77848434 | 9.90 |
ENSRNOT00000034342
|
Slc25a21
|
solute carrier family 25 member 21 |
chr2_-_157759819 | 9.89 |
ENSRNOT00000015763
ENSRNOT00000016016 |
LOC100909712
|
cyclin-L1-like |
chr17_-_31706523 | 9.84 |
ENSRNOT00000071312
|
AABR07027447.1
|
|
chr2_-_112831476 | 9.80 |
ENSRNOT00000018055
|
Ect2
|
epithelial cell transforming 2 |
chr13_-_89306219 | 9.77 |
ENSRNOT00000004183
ENSRNOT00000079247 |
Fcrla
|
Fc receptor-like A |
chr8_-_49301125 | 9.74 |
ENSRNOT00000091190
|
Cd3e
|
CD3e molecule |
chr14_+_38030189 | 9.73 |
ENSRNOT00000035623
|
Txk
|
TXK tyrosine kinase |
chr15_+_32832035 | 9.73 |
ENSRNOT00000060250
|
AABR07017902.1
|
|
chr14_+_17247362 | 9.72 |
ENSRNOT00000030222
|
Sdad1
|
SDA1 domain containing 1 |
chrX_-_123600890 | 9.72 |
ENSRNOT00000067942
|
Sept6
|
septin 6 |
chr4_+_102351036 | 9.71 |
ENSRNOT00000079277
|
AABR07060994.1
|
|
chr17_-_43675934 | 9.70 |
ENSRNOT00000081345
|
Hist1h1t
|
histone cluster 1 H1 family member t |
chr6_-_138536321 | 9.52 |
ENSRNOT00000077743
|
AABR07065643.1
|
|
chr6_-_138852571 | 9.51 |
ENSRNOT00000081803
|
AABR07065656.8
|
|
chr5_-_58183017 | 9.51 |
ENSRNOT00000020982
|
Ccl19
|
C-C motif chemokine ligand 19 |
chr3_+_19495628 | 9.50 |
ENSRNOT00000077990
|
Igkv4-57
|
immunoglobulin kappa variable 4-57 |
chr15_-_34693034 | 9.47 |
ENSRNOT00000083314
|
Mcpt8
|
mast cell protease 8 |
chr12_-_2661565 | 9.44 |
ENSRNOT00000064859
|
Cd209f
|
CD209f antigen |
chr19_-_56126063 | 9.41 |
ENSRNOT00000022658
|
Fanca
|
Fanconi anemia, complementation group A |
chr14_+_21177237 | 9.36 |
ENSRNOT00000004866
|
Jchain
|
immunoglobulin joining chain |
chr1_+_199720038 | 9.35 |
ENSRNOT00000027297
|
Ahsp
|
alpha hemoglobin stabilizing protein |
chr6_+_139523337 | 9.31 |
ENSRNOT00000090711
|
AABR07065699.4
|
|
chr9_-_10757954 | 9.26 |
ENSRNOT00000075265
|
Uhrf1
|
ubiquitin-like with PHD and ring finger domains 1 |
chr4_+_170518673 | 9.26 |
ENSRNOT00000011803
|
Atf7ip
|
activating transcription factor 7 interacting protein |
chr1_-_91588609 | 9.16 |
ENSRNOT00000050931
|
Snrpg
|
small nuclear ribonucleoprotein polypeptide G |
chr8_-_87158368 | 9.11 |
ENSRNOT00000077071
|
Col12a1
|
collagen type XII alpha 1 chain |
chr6_-_139041812 | 9.10 |
ENSRNOT00000074510
|
AABR07065656.1
|
|
chr4_+_69435703 | 9.07 |
ENSRNOT00000065485
|
LOC100911271
|
uncharacterized LOC100911271 |
chr6_-_104289668 | 9.02 |
ENSRNOT00000085646
|
Erh
|
enhancer of rudimentary homolog (Drosophila) |
chr12_-_46493203 | 9.00 |
ENSRNOT00000057036
|
Cit
|
citron rho-interacting serine/threonine kinase |
chr14_+_10534423 | 8.97 |
ENSRNOT00000002983
|
Hpse
|
heparanase |
chr8_+_117600749 | 8.95 |
ENSRNOT00000047482
|
Nckipsd
|
NCK interacting protein with SH3 domain |
chr19_+_14523554 | 8.93 |
ENSRNOT00000084271
ENSRNOT00000064731 |
Mcm5
|
minichromosome maintenance complex component 5 |
chr1_+_199323628 | 8.84 |
ENSRNOT00000036187
|
Zfp646
|
zinc finger protein 646 |
chr4_-_157408176 | 8.83 |
ENSRNOT00000021915
|
Cd4
|
Cd4 molecule |
chr17_-_44840131 | 8.80 |
ENSRNOT00000083417
|
Hist1h3b
|
histone cluster 1, H3b |
chr2_-_200762206 | 8.77 |
ENSRNOT00000068511
ENSRNOT00000086835 |
Hsd3b2
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 |
chr3_+_112531703 | 8.76 |
ENSRNOT00000041727
|
LOC100911204
|
protein CASC5-like |
chr10_-_25890639 | 8.76 |
ENSRNOT00000085499
|
Hmmr
|
hyaluronan-mediated motility receptor |
chr2_+_93792601 | 8.75 |
ENSRNOT00000014701
ENSRNOT00000077311 |
Fabp4
|
fatty acid binding protein 4 |
chr16_-_48692476 | 8.72 |
ENSRNOT00000013118
|
Irf2
|
interferon regulatory factor 2 |
chr4_+_67165883 | 8.72 |
ENSRNOT00000012280
|
Rab19
|
RAB19, member RAS oncogene family |
chr1_-_169005190 | 8.65 |
ENSRNOT00000043719
|
Hbe1
|
hemoglobin subunit epsilon 1 |
chr11_+_54619129 | 8.65 |
ENSRNOT00000059924
|
Trat1
|
T cell receptor associated transmembrane adaptor 1 |
chr6_-_141321108 | 8.62 |
ENSRNOT00000040556
|
AABR07065789.3
|
|
chr6_-_138772894 | 8.61 |
ENSRNOT00000080779
|
AABR07065651.1
|
|
chr1_+_167539036 | 8.60 |
ENSRNOT00000093112
|
Rrm1
|
ribonucleotide reductase catalytic subunit M1 |
chr20_+_3875706 | 8.59 |
ENSRNOT00000036900
|
RT1-Ha
|
RT1 class II, locus Ha |
chr2_+_231941794 | 8.54 |
ENSRNOT00000091475
|
AABR07013288.4
|
|
chr19_+_49462129 | 8.54 |
ENSRNOT00000015158
|
Cenpn
|
centromere protein N |
chr17_-_90149894 | 8.51 |
ENSRNOT00000024272
|
Apbb1ip
|
amyloid beta precursor protein binding family B member 1 interacting protein |
chr6_+_128738388 | 8.47 |
ENSRNOT00000050204
|
Rpl6-ps1
|
ribosomal protein L6, pseudogene 1 |
chr14_-_43143973 | 8.40 |
ENSRNOT00000003248
|
Uchl1
|
ubiquitin C-terminal hydrolase L1 |
chr6_-_139747737 | 8.37 |
ENSRNOT00000090626
|
AABR07065705.3
|
|
chr15_-_44411004 | 8.33 |
ENSRNOT00000031163
|
Cdca2
|
cell division cycle associated 2 |
chr10_-_15928169 | 8.29 |
ENSRNOT00000028069
|
Nsg2
|
neuron specific gene family member 2 |
chr8_-_117932518 | 8.24 |
ENSRNOT00000028130
|
Camp
|
cathelicidin antimicrobial peptide |
chr9_-_119871382 | 8.23 |
ENSRNOT00000018644
|
Ndc80
|
NDC80 kinetochore complex component |
chr2_-_219094730 | 8.22 |
ENSRNOT00000077972
|
Vcam1
|
vascular cell adhesion molecule 1 |
chr20_+_1809078 | 8.22 |
ENSRNOT00000084853
|
Olr1739
|
olfactory receptor 1739 |
chr3_+_72385666 | 8.20 |
ENSRNOT00000011168
|
Prg2
|
proteoglycan 2 |
chr16_-_36080191 | 8.20 |
ENSRNOT00000017635
|
Hmgb2l1
|
high mobility group box 2-like 1 |
chr6_+_139551751 | 8.16 |
ENSRNOT00000081684
|
AABR07065699.2
|
|
chr18_+_86299463 | 8.15 |
ENSRNOT00000058152
|
Cd226
|
CD226 molecule |
chr8_+_21905865 | 8.14 |
ENSRNOT00000027973
|
Ppan
|
peter pan homolog (Drosophila) |
chr1_-_271275989 | 8.11 |
ENSRNOT00000075570
|
LOC100912218
|
inositol 1,4,5-trisphosphate receptor-interacting protein-like |
chr2_+_212257225 | 8.08 |
ENSRNOT00000077883
|
Vav3
|
vav guanine nucleotide exchange factor 3 |
chr8_+_55603968 | 8.05 |
ENSRNOT00000066848
|
Pou2af1
|
POU class 2 associating factor 1 |
chr10_-_31493419 | 8.01 |
ENSRNOT00000009211
|
Itk
|
IL2-inducible T-cell kinase |
chr1_-_88162583 | 8.00 |
ENSRNOT00000087411
|
Catsperg
|
cation channel sperm associated auxiliary subunit gamma |
chr8_-_69121192 | 7.92 |
ENSRNOT00000012404
|
Zwilch
|
zwilch kinetochore protein |
chr12_-_51877624 | 7.92 |
ENSRNOT00000056800
|
Chek2
|
checkpoint kinase 2 |
chr9_-_23493081 | 7.90 |
ENSRNOT00000072144
|
Rhag
|
Rh-associated glycoprotein |
chr1_-_212330349 | 7.90 |
ENSRNOT00000024369
|
Adam8
|
ADAM metallopeptidase domain 8 |
chr4_+_160020472 | 7.83 |
ENSRNOT00000078802
|
Parp11
|
poly (ADP-ribose) polymerase family, member 11 |
chr4_-_113866674 | 7.82 |
ENSRNOT00000010020
|
Dok1
|
docking protein 1 |
chr2_-_30458542 | 7.80 |
ENSRNOT00000072926
|
Naip6
|
NLR family, apoptosis inhibitory protein 6 |
chr6_+_139486942 | 7.80 |
ENSRNOT00000080320
|
AABR07065699.3
|
|
chr1_-_104202591 | 7.79 |
ENSRNOT00000035512
|
E2f8
|
E2F transcription factor 8 |
chr6_-_138631997 | 7.77 |
ENSRNOT00000073304
|
AABR07065651.3
|
|
chr8_+_107499262 | 7.69 |
ENSRNOT00000081029
|
Cep70
|
centrosomal protein 70 |
chr1_-_1392329 | 7.69 |
ENSRNOT00000075346
|
AABR07000137.1
|
|
chr17_+_47870611 | 7.69 |
ENSRNOT00000078555
|
AABR07027872.1
|
|
chr8_+_61762768 | 7.66 |
ENSRNOT00000058685
ENSRNOT00000089557 |
Sin3a
|
SIN3 transcription regulator family member A |
chr15_+_57221292 | 7.66 |
ENSRNOT00000014502
|
Lcp1
|
lymphocyte cytosolic protein 1 |
chr8_+_48382121 | 7.65 |
ENSRNOT00000008685
|
Thy1
|
Thy-1 cell surface antigen |
chr16_+_26483463 | 7.63 |
ENSRNOT00000079010
|
LOC100910404
|
actin, cytoplasmic 2-like |
chr18_+_750776 | 7.62 |
ENSRNOT00000021981
|
Zfp136
|
zinc finger protein 136 |
chr15_+_31097291 | 7.61 |
ENSRNOT00000075456
|
AABR07017789.1
|
|
chr13_-_44798543 | 7.60 |
ENSRNOT00000005355
|
Zranb3
|
zinc finger RANBP2-type containing 3 |
chr13_-_108178609 | 7.60 |
ENSRNOT00000004525
|
Cenpf
|
centromere protein F |
chr7_+_116655145 | 7.58 |
ENSRNOT00000009823
|
Zfp41
|
zinc finger protein 41 |
chr17_+_15429708 | 7.58 |
ENSRNOT00000093261
|
LOC679342
|
hypothetical protein LOC679342 |
chr14_-_82347679 | 7.55 |
ENSRNOT00000032972
|
Tacc3
|
transforming, acidic coiled-coil containing protein 3 |
chr3_-_16750564 | 7.52 |
ENSRNOT00000084111
|
AABR07051548.1
|
|
chr11_+_60336061 | 7.51 |
ENSRNOT00000084022
|
LOC685767
|
similar to OX-2 membrane glycoprotein precursor (MRC OX-2 antigen) (CD200 antigen) |
chr1_+_173252058 | 7.50 |
ENSRNOT00000073421
|
LOC499229
|
similar to very large inducible GTPase 1 isoform A |
chr1_+_86973745 | 7.49 |
ENSRNOT00000078156
|
Rinl
|
Ras and Rab interactor-like |
chr14_+_71649274 | 7.47 |
ENSRNOT00000004128
|
Fgfbp1
|
fibroblast growth factor binding protein 1 |
chr10_+_45258887 | 7.44 |
ENSRNOT00000048642
|
Btnl10
|
butyrophilin like 10 |
chr11_+_85430400 | 7.40 |
ENSRNOT00000083198
|
AABR07034729.1
|
|
chr19_+_37652969 | 7.39 |
ENSRNOT00000041970
|
Carmil2
|
capping protein regulator and myosin 1 linker 2 |
chr7_+_102586313 | 7.38 |
ENSRNOT00000006188
|
Myc
|
myelocytomatosis oncogene |
chr19_-_43911057 | 7.36 |
ENSRNOT00000026017
|
Ctrb1
|
chymotrypsinogen B1 |
chr20_+_4020317 | 7.34 |
ENSRNOT00000000526
|
RT1-DOb
|
RT1 class II, locus DOb |
chr2_+_40000313 | 7.34 |
ENSRNOT00000014270
|
Depdc1b
|
DEP domain containing 1B |
chr4_+_69295641 | 7.33 |
ENSRNOT00000079683
|
Trbv5
|
T cell receptor beta, variable 5 |
chr15_+_31417147 | 7.32 |
ENSRNOT00000092182
|
AABR07017824.2
|
|
chr15_-_59215803 | 7.31 |
ENSRNOT00000032301
|
Lacc1
|
laccase domain containing 1 |
chr13_+_99184564 | 7.26 |
ENSRNOT00000004379
|
Pycr2
|
pyrroline-5-carboxylate reductase family, member 2 |
chr7_-_54778848 | 7.25 |
ENSRNOT00000005399
|
Glipr1
|
GLI pathogenesis-related 1 |
chr1_+_91005261 | 7.25 |
ENSRNOT00000081282
|
Wdr62
|
WD repeat domain 62 |
chr13_+_53283855 | 7.24 |
ENSRNOT00000043590
|
RGD1564839
|
similar to ribosomal protein L31 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.7 | 26.0 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
6.8 | 20.3 | GO:2000845 | positive regulation of testosterone secretion(GO:2000845) |
6.4 | 50.9 | GO:0016584 | nucleosome positioning(GO:0016584) |
4.8 | 19.2 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
4.4 | 13.1 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
4.2 | 12.5 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) cellular response to L-ascorbic acid(GO:0071298) |
4.1 | 12.4 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
3.8 | 22.9 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
3.6 | 10.8 | GO:1900060 | negative regulation of ceramide biosynthetic process(GO:1900060) |
3.5 | 17.7 | GO:0061056 | sclerotome development(GO:0061056) |
3.5 | 21.3 | GO:0034757 | negative regulation of iron ion transport(GO:0034757) |
3.2 | 9.6 | GO:0035419 | activation of MAPK activity involved in innate immune response(GO:0035419) |
3.2 | 9.6 | GO:0002223 | stimulatory C-type lectin receptor signaling pathway(GO:0002223) |
3.1 | 12.2 | GO:1990478 | response to ultrasound(GO:1990478) |
3.0 | 12.0 | GO:0042376 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
3.0 | 9.0 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
2.9 | 11.4 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
2.8 | 11.3 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
2.8 | 19.5 | GO:0070269 | pyroptosis(GO:0070269) |
2.7 | 8.2 | GO:0002215 | defense response to nematode(GO:0002215) |
2.7 | 8.2 | GO:0060369 | positive regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060369) |
2.6 | 7.7 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
2.5 | 7.4 | GO:0044330 | canonical Wnt signaling pathway involved in positive regulation of wound healing(GO:0044330) canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) metanephric cap development(GO:0072185) metanephric cap morphogenesis(GO:0072186) metanephric cap mesenchymal cell proliferation involved in metanephros development(GO:0090094) response to putrescine(GO:1904585) cellular response to putrescine(GO:1904586) |
2.4 | 9.7 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
2.4 | 7.3 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
2.4 | 16.6 | GO:0051126 | negative regulation of actin nucleation(GO:0051126) |
2.4 | 4.7 | GO:0071477 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
2.4 | 9.4 | GO:1903463 | regulation of mitotic cell cycle DNA replication(GO:1903463) |
2.3 | 11.4 | GO:0036215 | positive regulation of exit from mitosis(GO:0031536) response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) |
2.3 | 18.1 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
2.2 | 6.7 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
2.2 | 26.3 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
2.2 | 17.4 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
2.2 | 2.2 | GO:0090156 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) |
2.1 | 2.1 | GO:0051037 | regulation of transcription involved in meiotic cell cycle(GO:0051037) |
2.1 | 2.1 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
2.1 | 8.4 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
2.1 | 8.2 | GO:0071224 | cellular response to peptidoglycan(GO:0071224) |
2.0 | 10.1 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
2.0 | 12.0 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
2.0 | 6.0 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
2.0 | 53.4 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
1.9 | 9.7 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
1.9 | 5.7 | GO:1900095 | random inactivation of X chromosome(GO:0060816) regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
1.9 | 13.4 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
1.9 | 1.9 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
1.9 | 9.4 | GO:0034721 | histone H3-K4 demethylation, trimethyl-H3-K4-specific(GO:0034721) |
1.8 | 7.4 | GO:2000813 | negative regulation of barbed-end actin filament capping(GO:2000813) |
1.8 | 5.4 | GO:0002572 | pro-T cell differentiation(GO:0002572) cell proliferation involved in mesonephros development(GO:0061209) |
1.8 | 7.2 | GO:0034240 | negative regulation of macrophage fusion(GO:0034240) |
1.8 | 125.4 | GO:0006334 | nucleosome assembly(GO:0006334) |
1.8 | 5.4 | GO:0001966 | thigmotaxis(GO:0001966) |
1.8 | 12.5 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
1.8 | 14.2 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
1.8 | 3.5 | GO:1902544 | regulation of DNA N-glycosylase activity(GO:1902544) |
1.7 | 5.2 | GO:0071461 | cellular response to redox state(GO:0071461) |
1.7 | 19.2 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
1.7 | 5.1 | GO:1905218 | cellular response to astaxanthin(GO:1905218) |
1.7 | 136.4 | GO:0006342 | chromatin silencing(GO:0006342) |
1.7 | 5.0 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
1.7 | 5.0 | GO:0002554 | serotonin secretion by platelet(GO:0002554) |
1.6 | 8.2 | GO:0035926 | chemokine (C-C motif) ligand 2 secretion(GO:0035926) |
1.6 | 6.4 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
1.6 | 4.8 | GO:0014739 | positive regulation of muscle hyperplasia(GO:0014739) |
1.6 | 4.8 | GO:0072566 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) |
1.6 | 4.8 | GO:0060166 | olfactory pit development(GO:0060166) |
1.6 | 6.3 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
1.6 | 6.3 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
1.6 | 4.7 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
1.6 | 4.7 | GO:1904976 | cellular response to bleomycin(GO:1904976) |
1.6 | 9.4 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
1.5 | 4.6 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
1.5 | 4.5 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
1.5 | 2.9 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
1.4 | 18.6 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
1.4 | 9.9 | GO:0090166 | Golgi disassembly(GO:0090166) |
1.4 | 2.8 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
1.4 | 4.2 | GO:0071348 | cellular response to interleukin-11(GO:0071348) |
1.4 | 4.2 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
1.4 | 7.0 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
1.4 | 13.9 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
1.4 | 2.8 | GO:0035709 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
1.4 | 4.1 | GO:0009177 | pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
1.4 | 5.4 | GO:0002343 | peripheral B cell selection(GO:0002343) B cell affinity maturation(GO:0002344) response to symbiont(GO:0009608) |
1.4 | 17.6 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
1.4 | 5.4 | GO:1905168 | positive regulation of double-strand break repair via homologous recombination(GO:1905168) replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
1.3 | 4.0 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
1.3 | 4.0 | GO:0019303 | D-ribose catabolic process(GO:0019303) |
1.3 | 7.8 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
1.3 | 5.2 | GO:1903576 | response to L-arginine(GO:1903576) |
1.3 | 3.8 | GO:0090367 | regulation of mRNA modification(GO:0090365) negative regulation of mRNA modification(GO:0090367) |
1.3 | 9.0 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
1.3 | 10.2 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
1.3 | 5.1 | GO:0002729 | positive regulation of natural killer cell cytokine production(GO:0002729) |
1.3 | 7.6 | GO:0048478 | replication fork protection(GO:0048478) |
1.2 | 9.9 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
1.2 | 11.1 | GO:0022614 | membrane to membrane docking(GO:0022614) |
1.2 | 16.0 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
1.2 | 3.7 | GO:0035723 | interleukin-15-mediated signaling pathway(GO:0035723) cellular response to interleukin-15(GO:0071350) |
1.2 | 7.2 | GO:0032202 | telomere assembly(GO:0032202) |
1.2 | 3.6 | GO:0060101 | negative regulation of phagocytosis, engulfment(GO:0060101) |
1.2 | 8.3 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
1.2 | 3.6 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
1.2 | 14.2 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
1.2 | 3.5 | GO:0060490 | orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
1.1 | 4.5 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
1.1 | 4.5 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
1.1 | 2.2 | GO:0001805 | type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
1.1 | 5.6 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
1.1 | 10.1 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
1.1 | 13.4 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
1.1 | 6.7 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
1.1 | 3.3 | GO:0048298 | positive regulation of isotype switching to IgA isotypes(GO:0048298) |
1.1 | 3.3 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
1.1 | 7.6 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
1.1 | 3.2 | GO:0097167 | circadian regulation of translation(GO:0097167) |
1.1 | 9.5 | GO:2000234 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
1.0 | 8.4 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
1.0 | 3.1 | GO:0097037 | heme export(GO:0097037) |
1.0 | 3.1 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
1.0 | 3.1 | GO:1903721 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
1.0 | 4.1 | GO:0060066 | oviduct development(GO:0060066) |
1.0 | 3.1 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
1.0 | 3.1 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
1.0 | 4.1 | GO:0099550 | trans-synaptic signaling by trans-synaptic complex(GO:0099545) trans-synaptic signalling, modulating synaptic transmission(GO:0099550) |
1.0 | 3.1 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
1.0 | 5.1 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
1.0 | 1.0 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
1.0 | 5.0 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
1.0 | 10.9 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
1.0 | 3.0 | GO:0035261 | external genitalia morphogenesis(GO:0035261) gall bladder development(GO:0061010) |
1.0 | 3.9 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
1.0 | 9.6 | GO:0001865 | NK T cell differentiation(GO:0001865) |
1.0 | 2.9 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
1.0 | 2.9 | GO:0018924 | mandelate metabolic process(GO:0018924) |
0.9 | 5.7 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) regulation of axon diameter(GO:0031133) |
0.9 | 2.8 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.9 | 3.8 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.9 | 1.9 | GO:0007356 | thorax and anterior abdomen determination(GO:0007356) |
0.9 | 4.6 | GO:0009115 | xanthine catabolic process(GO:0009115) xanthine metabolic process(GO:0046110) |
0.9 | 2.8 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
0.9 | 6.4 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.9 | 3.7 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
0.9 | 3.6 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
0.9 | 2.7 | GO:1902963 | regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902959) positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) regulation of aspartic-type peptidase activity(GO:1905245) positive regulation of aspartic-type peptidase activity(GO:1905247) |
0.9 | 4.4 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
0.9 | 2.7 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.9 | 5.2 | GO:0015074 | DNA integration(GO:0015074) |
0.9 | 5.2 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.9 | 2.6 | GO:1903936 | cellular response to sodium arsenite(GO:1903936) |
0.9 | 15.5 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.9 | 7.7 | GO:0015866 | ADP transport(GO:0015866) |
0.9 | 3.4 | GO:0071651 | positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
0.9 | 2.6 | GO:1901535 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.8 | 1.7 | GO:1990869 | response to chemokine(GO:1990868) cellular response to chemokine(GO:1990869) |
0.8 | 22.9 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.8 | 2.5 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.8 | 4.2 | GO:0015793 | glycerol transport(GO:0015793) |
0.8 | 3.4 | GO:0002579 | positive regulation of antigen processing and presentation(GO:0002579) |
0.8 | 5.0 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.8 | 2.5 | GO:0033575 | protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
0.8 | 5.7 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.8 | 4.1 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.8 | 9.8 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.8 | 2.4 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.8 | 4.8 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.8 | 2.3 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
0.8 | 4.7 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.8 | 4.6 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.8 | 3.9 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.8 | 3.9 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.8 | 2.3 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.8 | 1.5 | GO:0052564 | response to immune response of other organism involved in symbiotic interaction(GO:0052564) response to host immune response(GO:0052572) |
0.8 | 5.3 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.8 | 10.5 | GO:0006968 | cellular defense response(GO:0006968) |
0.8 | 14.3 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.7 | 3.7 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.7 | 6.0 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.7 | 0.7 | GO:0090172 | microtubule cytoskeleton organization involved in homologous chromosome segregation(GO:0090172) |
0.7 | 14.9 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.7 | 2.2 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
0.7 | 1.5 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) regulation of T-helper 17 cell lineage commitment(GO:2000328) |
0.7 | 3.7 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.7 | 2.9 | GO:0009157 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) |
0.7 | 4.4 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.7 | 4.4 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.7 | 7.3 | GO:1904627 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
0.7 | 10.1 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.7 | 2.1 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.7 | 1.4 | GO:0042223 | regulation of interleukin-3 production(GO:0032672) positive regulation of interleukin-3 production(GO:0032752) interleukin-3 biosynthetic process(GO:0042223) regulation of interleukin-3 biosynthetic process(GO:0045399) positive regulation of interleukin-3 biosynthetic process(GO:0045401) positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045425) |
0.7 | 6.3 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.7 | 5.6 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.7 | 9.1 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.7 | 9.1 | GO:1902751 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.7 | 18.7 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.7 | 4.1 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.7 | 11.0 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.7 | 2.8 | GO:0032919 | spermine acetylation(GO:0032919) |
0.7 | 1.4 | GO:0061534 | gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
0.7 | 10.2 | GO:0015671 | oxygen transport(GO:0015671) |
0.7 | 3.3 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.7 | 4.0 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.7 | 28.1 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.7 | 1.3 | GO:0010994 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.7 | 7.9 | GO:0006265 | DNA topological change(GO:0006265) |
0.7 | 7.2 | GO:0002467 | germinal center formation(GO:0002467) |
0.7 | 2.6 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.7 | 7.8 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.6 | 1.3 | GO:0070340 | detection of diacyl bacterial lipopeptide(GO:0042496) detection of bacterial lipopeptide(GO:0070340) |
0.6 | 9.7 | GO:0043306 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.6 | 3.9 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.6 | 4.5 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.6 | 3.2 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.6 | 3.2 | GO:0033227 | dsRNA transport(GO:0033227) |
0.6 | 2.5 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.6 | 17.0 | GO:0070303 | negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
0.6 | 2.5 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.6 | 2.5 | GO:0072249 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
0.6 | 1.8 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.6 | 3.7 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.6 | 4.8 | GO:0033089 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.6 | 1.8 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
0.6 | 6.6 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.6 | 4.8 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.6 | 1.8 | GO:0098507 | polynucleotide 5' dephosphorylation(GO:0098507) |
0.6 | 5.4 | GO:0003360 | brainstem development(GO:0003360) |
0.6 | 1.8 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.6 | 5.3 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
0.6 | 1.2 | GO:0006713 | glucocorticoid catabolic process(GO:0006713) |
0.6 | 4.1 | GO:0000012 | single strand break repair(GO:0000012) |
0.6 | 22.2 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.6 | 1.2 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
0.6 | 2.9 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.6 | 2.8 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.6 | 2.8 | GO:1904528 | positive regulation of microtubule binding(GO:1904528) |
0.6 | 2.8 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.6 | 3.3 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.6 | 2.2 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.6 | 2.8 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.6 | 6.1 | GO:0071028 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.5 | 1.6 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
0.5 | 2.7 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.5 | 2.7 | GO:0009838 | abscission(GO:0009838) |
0.5 | 2.7 | GO:0090169 | regulation of spindle assembly(GO:0090169) regulation of mitotic spindle assembly(GO:1901673) |
0.5 | 12.1 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.5 | 2.1 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.5 | 1.6 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.5 | 4.2 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.5 | 1.0 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.5 | 12.3 | GO:0006221 | pyrimidine nucleotide biosynthetic process(GO:0006221) |
0.5 | 2.0 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.5 | 7.6 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.5 | 1.5 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.5 | 6.0 | GO:0019985 | translesion synthesis(GO:0019985) |
0.5 | 3.0 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.5 | 7.0 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.5 | 1.5 | GO:0014908 | myotube differentiation involved in skeletal muscle regeneration(GO:0014908) |
0.5 | 2.0 | GO:0007296 | vitellogenesis(GO:0007296) |
0.5 | 4.8 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.5 | 7.2 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.5 | 2.9 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.5 | 1.9 | GO:1990164 | histone H2A phosphorylation(GO:1990164) |
0.5 | 2.4 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
0.5 | 1.9 | GO:0021586 | pons maturation(GO:0021586) |
0.5 | 2.8 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
0.5 | 3.7 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.5 | 3.7 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.5 | 7.9 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.5 | 1.4 | GO:0010979 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.5 | 3.2 | GO:0090179 | planar cell polarity pathway involved in neural tube closure(GO:0090179) |
0.5 | 7.8 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.5 | 3.7 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.5 | 7.4 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.5 | 3.2 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.5 | 3.7 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.4 | 9.0 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.4 | 1.3 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
0.4 | 5.4 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.4 | 0.9 | GO:0045799 | positive regulation of chromatin assembly or disassembly(GO:0045799) |
0.4 | 1.3 | GO:0032218 | riboflavin transport(GO:0032218) |
0.4 | 7.0 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.4 | 4.8 | GO:0035510 | DNA dealkylation(GO:0035510) |
0.4 | 3.0 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.4 | 8.7 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.4 | 2.2 | GO:0032532 | regulation of microvillus length(GO:0032532) brush border assembly(GO:1904970) |
0.4 | 3.0 | GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
0.4 | 7.3 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.4 | 4.7 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.4 | 3.8 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.4 | 1.3 | GO:0014916 | regulation of lung blood pressure(GO:0014916) |
0.4 | 11.3 | GO:0030033 | microvillus assembly(GO:0030033) |
0.4 | 5.8 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.4 | 2.9 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.4 | 14.0 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.4 | 2.4 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.4 | 5.7 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.4 | 1.2 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.4 | 2.0 | GO:1901656 | glycoside transport(GO:1901656) |
0.4 | 1.2 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
0.4 | 1.6 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.4 | 0.4 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.4 | 1.6 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
0.4 | 2.4 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.4 | 1.6 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.4 | 1.2 | GO:1990009 | retinal cell apoptotic process(GO:1990009) |
0.4 | 13.0 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.4 | 5.9 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.4 | 1.2 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.4 | 3.9 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.4 | 1.2 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.4 | 1.2 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.4 | 7.7 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.4 | 1.5 | GO:0070666 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) negative regulation of mast cell apoptotic process(GO:0033026) mast cell proliferation(GO:0070662) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
0.4 | 1.5 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.4 | 7.5 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.4 | 1.1 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.4 | 2.6 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.4 | 4.4 | GO:0048535 | lymph node development(GO:0048535) |
0.4 | 9.5 | GO:0030488 | tRNA methylation(GO:0030488) |
0.4 | 15.6 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.4 | 1.1 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.4 | 2.1 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.4 | 3.2 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.3 | 4.2 | GO:0050718 | positive regulation of interleukin-1 secretion(GO:0050716) positive regulation of interleukin-1 beta secretion(GO:0050718) |
0.3 | 0.7 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.3 | 1.4 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.3 | 1.0 | GO:0019042 | viral latency(GO:0019042) release from viral latency(GO:0019046) |
0.3 | 1.0 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) |
0.3 | 1.0 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
0.3 | 0.7 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
0.3 | 2.7 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.3 | 0.7 | GO:0045726 | positive regulation of integrin biosynthetic process(GO:0045726) |
0.3 | 4.0 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.3 | 3.0 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.3 | 2.6 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.3 | 4.2 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
0.3 | 12.1 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.3 | 1.6 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.3 | 4.4 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.3 | 1.9 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.3 | 4.4 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.3 | 1.3 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
0.3 | 0.9 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.3 | 0.6 | GO:0061740 | late endosomal microautophagy(GO:0061738) protein targeting to lysosome involved in chaperone-mediated autophagy(GO:0061740) regulation of lysosomal membrane permeability(GO:0097213) positive regulation of lysosomal membrane permeability(GO:0097214) |
0.3 | 2.8 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.3 | 8.0 | GO:0007099 | centriole replication(GO:0007099) |
0.3 | 1.8 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.3 | 1.5 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
0.3 | 3.9 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.3 | 7.3 | GO:0007143 | female meiotic division(GO:0007143) |
0.3 | 7.5 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.3 | 1.5 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.3 | 1.5 | GO:0044704 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.3 | 1.8 | GO:0015886 | heme transport(GO:0015886) |
0.3 | 3.3 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.3 | 4.4 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.3 | 5.0 | GO:0007398 | ectoderm development(GO:0007398) |
0.3 | 2.0 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.3 | 1.1 | GO:0046618 | drug export(GO:0046618) |
0.3 | 3.7 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.3 | 1.1 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.3 | 0.8 | GO:0090671 | RNA localization to Cajal body(GO:0090670) telomerase RNA localization to Cajal body(GO:0090671) telomerase RNA localization(GO:0090672) |
0.3 | 1.7 | GO:0043485 | endosome to melanosome transport(GO:0035646) pigment accumulation(GO:0043476) cellular pigment accumulation(GO:0043482) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.3 | 1.9 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.3 | 1.6 | GO:0034969 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) histone arginine methylation(GO:0034969) |
0.3 | 4.5 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
0.3 | 5.3 | GO:0045576 | mast cell activation(GO:0045576) |
0.3 | 2.1 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
0.3 | 1.8 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
0.3 | 0.5 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
0.3 | 2.0 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.3 | 3.1 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) |
0.3 | 0.8 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.3 | 2.3 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.2 | 1.7 | GO:0006337 | nucleosome disassembly(GO:0006337) |
0.2 | 1.0 | GO:0043328 | protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.2 | 5.0 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.2 | 0.7 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.2 | 1.0 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.2 | 1.2 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.2 | 2.4 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.2 | 1.7 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.2 | 1.7 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.2 | 0.7 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.2 | 10.1 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.2 | 0.9 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.2 | 0.5 | GO:0002576 | platelet degranulation(GO:0002576) |
0.2 | 2.1 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.2 | 3.7 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.2 | 0.7 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.2 | 0.9 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.2 | 2.1 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.2 | 3.4 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.2 | 0.7 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.2 | 1.1 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.2 | 10.2 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.2 | 0.7 | GO:0043486 | histone exchange(GO:0043486) |
0.2 | 2.5 | GO:0046640 | regulation of alpha-beta T cell proliferation(GO:0046640) positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.2 | 7.8 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.2 | 1.3 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.2 | 1.8 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.2 | 1.1 | GO:2000332 | blood microparticle formation(GO:0072564) regulation of blood microparticle formation(GO:2000332) positive regulation of blood microparticle formation(GO:2000334) |
0.2 | 2.4 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.2 | 7.4 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.2 | 6.1 | GO:0071427 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.2 | 2.1 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.2 | 2.5 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.2 | 0.8 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.2 | 7.7 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.2 | 1.4 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.2 | 2.8 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.2 | 1.6 | GO:0097435 | fibril organization(GO:0097435) |
0.2 | 2.6 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.2 | 1.6 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.2 | 0.6 | GO:0015744 | succinate transport(GO:0015744) succinate transmembrane transport(GO:0071422) |
0.2 | 3.2 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.2 | 6.7 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.2 | 5.6 | GO:0007004 | RNA-dependent DNA biosynthetic process(GO:0006278) telomere maintenance via telomerase(GO:0007004) |
0.2 | 0.6 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.2 | 2.2 | GO:0031167 | rRNA methylation(GO:0031167) |
0.2 | 1.7 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.2 | 0.6 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.2 | 1.8 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.2 | 0.9 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.2 | 2.7 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.2 | 1.1 | GO:0021553 | olfactory nerve development(GO:0021553) |
0.2 | 3.3 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.2 | 2.6 | GO:0006405 | RNA export from nucleus(GO:0006405) |
0.2 | 0.8 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.2 | 3.3 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.2 | 1.7 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.2 | 3.6 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.2 | 0.8 | GO:0071233 | cellular response to leucine(GO:0071233) |
0.2 | 1.5 | GO:1901550 | sphingosine-1-phosphate signaling pathway(GO:0003376) negative regulation of endothelial cell differentiation(GO:0045602) regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.2 | 0.7 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
0.2 | 0.5 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
0.2 | 1.6 | GO:0045916 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.2 | 1.1 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
0.2 | 6.2 | GO:0048002 | antigen processing and presentation of peptide antigen(GO:0048002) |
0.2 | 0.6 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.2 | 3.8 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.2 | 1.1 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.2 | 1.6 | GO:0014842 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
0.2 | 1.5 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
0.2 | 3.3 | GO:0045047 | protein targeting to ER(GO:0045047) |
0.2 | 7.7 | GO:0008543 | fibroblast growth factor receptor signaling pathway(GO:0008543) |
0.1 | 0.9 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.1 | 0.3 | GO:0042350 | GDP-L-fucose biosynthetic process(GO:0042350) |
0.1 | 3.9 | GO:0019835 | cytolysis(GO:0019835) |
0.1 | 0.7 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
0.1 | 2.8 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.1 | 0.9 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.1 | 1.6 | GO:0010390 | histone monoubiquitination(GO:0010390) |
0.1 | 0.8 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.1 | 2.7 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.1 | 0.8 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.1 | 2.5 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.1 | 1.4 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.1 | 9.3 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.1 | 4.1 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.1 | 1.2 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.1 | 3.3 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.1 | 3.5 | GO:0097352 | autophagosome maturation(GO:0097352) vacuole fusion(GO:0097576) |
0.1 | 0.7 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.1 | 1.2 | GO:0009313 | ganglioside catabolic process(GO:0006689) oligosaccharide catabolic process(GO:0009313) |
0.1 | 0.5 | GO:0097401 | synaptic vesicle lumen acidification(GO:0097401) |
0.1 | 0.5 | GO:0031179 | cysteine biosynthetic process(GO:0019344) peptide modification(GO:0031179) |
0.1 | 2.3 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.1 | 8.0 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
0.1 | 0.1 | GO:0097187 | dentinogenesis(GO:0097187) |
0.1 | 6.2 | GO:0006414 | translational elongation(GO:0006414) |
0.1 | 1.5 | GO:0014894 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.1 | 1.5 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.1 | 1.0 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.1 | 0.7 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 1.4 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.1 | 0.2 | GO:1901523 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
0.1 | 1.3 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.1 | 7.0 | GO:0006413 | translational initiation(GO:0006413) |
0.1 | 0.3 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 0.7 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.1 | 1.1 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.1 | 1.0 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.1 | 0.3 | GO:0007141 | male meiosis I(GO:0007141) |
0.1 | 1.2 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.1 | 4.0 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
0.1 | 4.1 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.1 | 0.8 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.1 | 3.3 | GO:0035428 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
0.1 | 2.9 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.1 | 5.6 | GO:0030177 | positive regulation of Wnt signaling pathway(GO:0030177) |
0.1 | 1.3 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.1 | 0.9 | GO:0071872 | cellular response to epinephrine stimulus(GO:0071872) |
0.1 | 1.4 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 0.8 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.1 | 2.1 | GO:0051028 | mRNA transport(GO:0051028) |
0.1 | 3.2 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 1.2 | GO:0001556 | oocyte maturation(GO:0001556) |
0.1 | 1.0 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.1 | 1.0 | GO:1903846 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.1 | 0.9 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 2.5 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.1 | 1.0 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 3.1 | GO:0002224 | toll-like receptor signaling pathway(GO:0002224) |
0.1 | 2.0 | GO:0046902 | regulation of mitochondrial membrane permeability(GO:0046902) |
0.1 | 1.2 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.1 | 0.8 | GO:0006415 | translational termination(GO:0006415) |
0.1 | 3.2 | GO:0009880 | embryonic pattern specification(GO:0009880) |
0.1 | 5.4 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.1 | 0.8 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.1 | 2.2 | GO:0014068 | positive regulation of phosphatidylinositol 3-kinase signaling(GO:0014068) |
0.1 | 0.8 | GO:0030238 | male sex determination(GO:0030238) |
0.1 | 1.9 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.1 | 0.5 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.1 | 0.8 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 | 0.1 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.1 | 0.2 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.1 | 1.7 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
0.1 | 0.3 | GO:0043418 | homocysteine catabolic process(GO:0043418) |
0.1 | 1.5 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.1 | 0.6 | GO:0048664 | neuron fate determination(GO:0048664) |
0.1 | 0.9 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 3.6 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
0.1 | 0.1 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.1 | 2.4 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.1 | 2.3 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.1 | 1.7 | GO:0045930 | negative regulation of mitotic cell cycle(GO:0045930) |
0.1 | 2.1 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.1 | 1.8 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.1 | 0.6 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.1 | 1.2 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.1 | 1.3 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.1 | 0.4 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 | 1.2 | GO:0051567 | histone H3-K9 methylation(GO:0051567) |
0.1 | 0.3 | GO:0010224 | response to UV-B(GO:0010224) |
0.1 | 1.6 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.1 | 0.6 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
0.1 | 3.4 | GO:0008380 | RNA splicing(GO:0008380) |
0.1 | 0.2 | GO:1903232 | melanosome assembly(GO:1903232) |
0.1 | 0.1 | GO:0046639 | negative regulation of alpha-beta T cell differentiation(GO:0046639) |
0.1 | 0.2 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.1 | 1.1 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 0.2 | GO:0032197 | transposition, RNA-mediated(GO:0032197) |
0.1 | 1.8 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.1 | 0.9 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.1 | 1.8 | GO:0045727 | positive regulation of translation(GO:0045727) |
0.1 | 0.9 | GO:2001020 | regulation of response to DNA damage stimulus(GO:2001020) |
0.1 | 1.9 | GO:0060976 | coronary vasculature development(GO:0060976) |
0.1 | 2.2 | GO:0018022 | peptidyl-lysine methylation(GO:0018022) |
0.1 | 1.5 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.1 | 0.4 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
0.1 | 0.3 | GO:0051414 | response to cortisol(GO:0051414) |
0.1 | 0.2 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 0.5 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 5.0 | GO:0000375 | RNA splicing, via transesterification reactions(GO:0000375) RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
0.1 | 0.3 | GO:0060723 | regulation of spongiotrophoblast cell proliferation(GO:0060721) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
0.1 | 0.5 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.1 | 4.7 | GO:0007586 | digestion(GO:0007586) |
0.0 | 1.0 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.0 | 0.5 | GO:0051593 | response to folic acid(GO:0051593) |
0.0 | 0.2 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
0.0 | 0.2 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.0 | 4.0 | GO:0090305 | nucleic acid phosphodiester bond hydrolysis(GO:0090305) |
0.0 | 0.2 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.0 | 0.4 | GO:0060013 | righting reflex(GO:0060013) |
0.0 | 2.0 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) |
0.0 | 0.5 | GO:1901642 | nucleoside transmembrane transport(GO:1901642) |
0.0 | 0.2 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.0 | 0.4 | GO:0034285 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
0.0 | 0.4 | GO:0051782 | negative regulation of cell division(GO:0051782) |
0.0 | 0.4 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.0 | 0.2 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.0 | 1.0 | GO:0070527 | platelet aggregation(GO:0070527) |
0.0 | 0.1 | GO:0038202 | TORC1 signaling(GO:0038202) |
0.0 | 0.4 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.0 | 0.4 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.0 | 0.2 | GO:0051182 | coenzyme transport(GO:0051182) |
0.0 | 0.3 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.0 | 0.4 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.0 | 0.1 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.0 | 0.1 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.0 | 2.0 | GO:0008037 | cell recognition(GO:0008037) |
0.0 | 0.3 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.0 | 0.1 | GO:0048820 | hair follicle maturation(GO:0048820) |
0.0 | 2.2 | GO:0006281 | DNA repair(GO:0006281) |
0.0 | 0.1 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.0 | 0.1 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.0 | 0.1 | GO:0051014 | actin filament severing(GO:0051014) |
0.0 | 0.8 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.0 | 0.1 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.0 | 0.2 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
12.2 | 36.7 | GO:0032173 | septin collar(GO:0032173) |
6.8 | 20.4 | GO:1990423 | RZZ complex(GO:1990423) |
6.5 | 26.0 | GO:0031436 | BRCA1-BARD1 complex(GO:0031436) |
4.4 | 17.6 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
4.1 | 404.0 | GO:0000786 | nucleosome(GO:0000786) |
4.0 | 16.1 | GO:0071065 | alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
3.4 | 16.9 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
3.3 | 26.6 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
3.3 | 9.9 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
3.0 | 14.8 | GO:0031262 | Ndc80 complex(GO:0031262) |
2.9 | 11.7 | GO:0031021 | interphase microtubule organizing center(GO:0031021) |
2.8 | 22.3 | GO:0044815 | DNA packaging complex(GO:0044815) |
2.8 | 11.1 | GO:0035339 | SPOTS complex(GO:0035339) |
2.7 | 22.0 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
2.5 | 5.0 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
2.5 | 9.8 | GO:0097149 | centralspindlin complex(GO:0097149) |
2.3 | 9.4 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
2.1 | 6.4 | GO:1990826 | nucleoplasmic periphery of the nuclear pore complex(GO:1990826) |
1.8 | 29.5 | GO:0042613 | MHC class II protein complex(GO:0042613) |
1.8 | 7.2 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
1.8 | 19.5 | GO:0042555 | MCM complex(GO:0042555) |
1.7 | 17.2 | GO:0042101 | T cell receptor complex(GO:0042101) |
1.6 | 11.0 | GO:0005683 | U7 snRNP(GO:0005683) |
1.5 | 4.4 | GO:1990590 | ATF1-ATF4 transcription factor complex(GO:1990590) |
1.4 | 7.0 | GO:0034455 | t-UTP complex(GO:0034455) |
1.4 | 5.4 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
1.4 | 6.8 | GO:1990130 | Iml1 complex(GO:1990130) |
1.4 | 5.4 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
1.3 | 6.5 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
1.3 | 11.7 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
1.2 | 9.9 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
1.2 | 2.4 | GO:0042585 | germinal vesicle(GO:0042585) |
1.2 | 3.5 | GO:0060187 | cell pole(GO:0060187) |
1.1 | 7.6 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
1.1 | 5.3 | GO:0097452 | GAIT complex(GO:0097452) |
1.0 | 3.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
1.0 | 4.2 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
1.0 | 3.0 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
1.0 | 13.7 | GO:0031616 | spindle pole centrosome(GO:0031616) |
1.0 | 15.6 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
1.0 | 3.9 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
1.0 | 4.8 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.9 | 2.8 | GO:0044609 | DBIRD complex(GO:0044609) |
0.9 | 10.2 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.9 | 2.7 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.9 | 2.7 | GO:0061673 | mitotic spindle astral microtubule(GO:0061673) |
0.9 | 8.6 | GO:0034709 | methylosome(GO:0034709) |
0.9 | 6.0 | GO:0090543 | Flemming body(GO:0090543) |
0.8 | 5.8 | GO:0036128 | CatSper complex(GO:0036128) |
0.8 | 5.0 | GO:0009279 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.8 | 2.5 | GO:0005668 | RNA polymerase transcription factor SL1 complex(GO:0005668) |
0.8 | 4.8 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.8 | 3.1 | GO:0070876 | SOSS complex(GO:0070876) |
0.8 | 31.2 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.8 | 3.1 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.8 | 3.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.7 | 3.7 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.7 | 5.1 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.7 | 20.4 | GO:0001891 | phagocytic cup(GO:0001891) |
0.7 | 52.8 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.7 | 4.3 | GO:0001940 | male pronucleus(GO:0001940) |
0.7 | 13.4 | GO:0001741 | XY body(GO:0001741) |
0.7 | 6.9 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.7 | 2.0 | GO:0032798 | Swi5-Sfr1 complex(GO:0032798) |
0.7 | 4.7 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.7 | 2.7 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.6 | 1.9 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.6 | 3.2 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.6 | 1.9 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.6 | 3.1 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.6 | 11.1 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.6 | 3.7 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.6 | 4.8 | GO:0016282 | eukaryotic 43S preinitiation complex(GO:0016282) |
0.6 | 9.4 | GO:0005682 | U5 snRNP(GO:0005682) |
0.6 | 2.9 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.6 | 10.6 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.6 | 5.2 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.6 | 2.9 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.6 | 4.6 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.6 | 1.7 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
0.6 | 21.5 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.6 | 3.9 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.6 | 2.8 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.6 | 2.8 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.5 | 7.7 | GO:0016580 | Sin3 complex(GO:0016580) |
0.5 | 8.8 | GO:0042581 | specific granule(GO:0042581) |
0.5 | 1.6 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
0.5 | 2.1 | GO:0044393 | microspike(GO:0044393) |
0.5 | 2.6 | GO:0071797 | LUBAC complex(GO:0071797) |
0.5 | 13.3 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.5 | 2.0 | GO:0000938 | GARP complex(GO:0000938) |
0.5 | 5.9 | GO:0000812 | Swr1 complex(GO:0000812) |
0.5 | 6.9 | GO:0031932 | TORC2 complex(GO:0031932) |
0.5 | 6.3 | GO:0035102 | PRC1 complex(GO:0035102) |
0.5 | 4.3 | GO:0033263 | CORVET complex(GO:0033263) |
0.5 | 4.6 | GO:0070187 | telosome(GO:0070187) |
0.5 | 16.6 | GO:0000791 | euchromatin(GO:0000791) |
0.5 | 2.3 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.5 | 5.0 | GO:0016600 | flotillin complex(GO:0016600) |
0.4 | 4.0 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.4 | 1.3 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.4 | 2.6 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.4 | 1.3 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.4 | 5.2 | GO:0008278 | cohesin complex(GO:0008278) |
0.4 | 1.3 | GO:0043511 | inhibin complex(GO:0043511) |
0.4 | 0.8 | GO:0001739 | sex chromatin(GO:0001739) |
0.4 | 38.2 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.4 | 2.8 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.4 | 4.0 | GO:0033202 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
0.4 | 15.8 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
0.4 | 6.7 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.4 | 3.5 | GO:0032009 | early phagosome(GO:0032009) |
0.4 | 2.7 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.4 | 29.2 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.4 | 2.9 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.4 | 1.1 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) post-mRNA release spliceosomal complex(GO:0071014) |
0.4 | 5.7 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.4 | 2.5 | GO:0005579 | membrane attack complex(GO:0005579) |
0.4 | 3.6 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.3 | 2.1 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.3 | 3.1 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.3 | 2.1 | GO:0000125 | PCAF complex(GO:0000125) |
0.3 | 2.0 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.3 | 1.3 | GO:0000803 | sex chromosome(GO:0000803) |
0.3 | 1.0 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.3 | 1.7 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.3 | 8.1 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.3 | 2.6 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.3 | 4.5 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.3 | 2.9 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.3 | 1.2 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.3 | 1.5 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.3 | 0.6 | GO:0032806 | holo TFIIH complex(GO:0005675) carboxy-terminal domain protein kinase complex(GO:0032806) |
0.3 | 2.7 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.3 | 8.0 | GO:0035861 | site of double-strand break(GO:0035861) |
0.3 | 1.5 | GO:0070938 | contractile ring(GO:0070938) |
0.3 | 8.9 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.3 | 10.4 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.3 | 1.7 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.3 | 1.4 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.3 | 2.2 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.3 | 2.8 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.3 | 3.6 | GO:0000800 | lateral element(GO:0000800) |
0.3 | 1.1 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.3 | 3.3 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.3 | 0.8 | GO:0038201 | TOR complex(GO:0038201) |
0.3 | 6.8 | GO:0042629 | mast cell granule(GO:0042629) |
0.3 | 74.4 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.3 | 12.0 | GO:0016235 | aggresome(GO:0016235) |
0.3 | 13.2 | GO:0072686 | mitotic spindle(GO:0072686) |
0.3 | 3.1 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.3 | 2.9 | GO:0035267 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.3 | 1.8 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.3 | 13.7 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.3 | 1.8 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.3 | 5.4 | GO:0034451 | centriolar satellite(GO:0034451) |
0.3 | 18.8 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.3 | 8.7 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.2 | 7.8 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.2 | 11.1 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.2 | 1.9 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.2 | 1.7 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.2 | 2.1 | GO:0097433 | dense body(GO:0097433) |
0.2 | 24.1 | GO:0005814 | centriole(GO:0005814) |
0.2 | 1.4 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.2 | 0.9 | GO:0002947 | tumor necrosis factor receptor superfamily complex(GO:0002947) |
0.2 | 3.4 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.2 | 11.5 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.2 | 1.8 | GO:0000242 | pericentriolar material(GO:0000242) |
0.2 | 2.0 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.2 | 171.3 | GO:0005730 | nucleolus(GO:0005730) |
0.2 | 10.2 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.2 | 0.6 | GO:0042382 | paraspeckles(GO:0042382) |
0.2 | 9.5 | GO:0000793 | condensed chromosome(GO:0000793) |
0.2 | 4.3 | GO:0042588 | zymogen granule(GO:0042588) |
0.2 | 1.1 | GO:1990393 | 3M complex(GO:1990393) |
0.2 | 3.7 | GO:0005876 | spindle microtubule(GO:0005876) |
0.2 | 2.2 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.2 | 1.6 | GO:0000792 | heterochromatin(GO:0000792) |
0.2 | 1.2 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.2 | 0.7 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.2 | 1.0 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.2 | 11.3 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.2 | 1.9 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.2 | 2.9 | GO:0031519 | PcG protein complex(GO:0031519) |
0.2 | 0.5 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.2 | 1.7 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.1 | 2.6 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 5.2 | GO:0005643 | nuclear pore(GO:0005643) |
0.1 | 6.5 | GO:0016605 | PML body(GO:0016605) |
0.1 | 32.9 | GO:0005694 | chromosome(GO:0005694) |
0.1 | 1.5 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.1 | 2.6 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 3.5 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 4.3 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 3.0 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.7 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.1 | 1.7 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.1 | 0.8 | GO:0032437 | cuticular plate(GO:0032437) |
0.1 | 2.1 | GO:0030904 | retromer complex(GO:0030904) |
0.1 | 2.2 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.3 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 1.2 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 1.2 | GO:0032426 | stereocilium tip(GO:0032426) |
0.1 | 0.1 | GO:0061574 | ASAP complex(GO:0061574) |
0.1 | 1.0 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.1 | 0.6 | GO:0019013 | viral nucleocapsid(GO:0019013) |
0.1 | 1.9 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 1.3 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 5.1 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 0.7 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.1 | 0.7 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 2.5 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 9.2 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 1.0 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.1 | 2.0 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 0.2 | GO:0042827 | platelet dense granule(GO:0042827) |
0.1 | 0.5 | GO:0045179 | apical cortex(GO:0045179) |
0.0 | 0.2 | GO:0000346 | transcription export complex(GO:0000346) |
0.0 | 0.1 | GO:0034657 | GID complex(GO:0034657) |
0.0 | 0.4 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.0 | 0.5 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.0 | 0.1 | GO:0005846 | nuclear cap binding complex(GO:0005846) |
0.0 | 2.3 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 0.3 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.0 | 0.4 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.6 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 0.1 | GO:0044299 | C-fiber(GO:0044299) |
0.0 | 0.2 | GO:0071437 | invadopodium(GO:0071437) |
0.0 | 0.1 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.0 | 0.3 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.0 | 0.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 0.7 | GO:0000922 | spindle pole(GO:0000922) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.1 | 21.3 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
4.3 | 21.6 | GO:0032564 | dATP binding(GO:0032564) |
4.2 | 20.9 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
3.3 | 10.0 | GO:0052723 | inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
3.2 | 9.5 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
3.0 | 8.9 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
2.9 | 17.6 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
2.8 | 11.1 | GO:0030492 | hemoglobin binding(GO:0030492) |
2.7 | 10.9 | GO:0015057 | thrombin receptor activity(GO:0015057) |
2.5 | 10.0 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
2.5 | 17.4 | GO:0003896 | DNA primase activity(GO:0003896) |
2.4 | 7.3 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
2.4 | 12.0 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
2.4 | 4.8 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
2.3 | 11.7 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
2.3 | 9.3 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
2.2 | 4.4 | GO:0035326 | enhancer binding(GO:0035326) |
2.2 | 26.3 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
2.1 | 8.4 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
2.0 | 8.2 | GO:0044378 | non-sequence-specific DNA binding, bending(GO:0044378) |
2.0 | 12.2 | GO:0032027 | myosin light chain binding(GO:0032027) |
1.9 | 9.4 | GO:0019862 | IgA binding(GO:0019862) |
1.7 | 6.9 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
1.7 | 5.1 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
1.7 | 5.0 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
1.6 | 9.7 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
1.6 | 9.4 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
1.6 | 12.5 | GO:0045545 | syndecan binding(GO:0045545) |
1.5 | 7.5 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
1.5 | 8.8 | GO:0042289 | MHC class II protein binding(GO:0042289) |
1.4 | 18.8 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
1.4 | 12.7 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
1.4 | 4.2 | GO:0015254 | glycerol channel activity(GO:0015254) |
1.4 | 4.2 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
1.4 | 4.2 | GO:0016505 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) peptidase activator activity involved in apoptotic process(GO:0016505) |
1.3 | 4.0 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
1.3 | 10.4 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
1.3 | 7.6 | GO:0034235 | GPI anchor binding(GO:0034235) |
1.2 | 4.7 | GO:0035827 | rubidium ion transmembrane transporter activity(GO:0035827) |
1.2 | 13.0 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
1.2 | 4.7 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
1.2 | 3.5 | GO:0008263 | pyrimidine-specific mismatch base pair DNA N-glycosylase activity(GO:0008263) |
1.2 | 10.4 | GO:1990446 | U1 snRNP binding(GO:1990446) |
1.1 | 10.2 | GO:0036310 | annealing helicase activity(GO:0036310) |
1.1 | 3.4 | GO:0070976 | TIR domain binding(GO:0070976) |
1.1 | 5.5 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
1.0 | 4.2 | GO:0000403 | Y-form DNA binding(GO:0000403) |
1.0 | 12.4 | GO:1990405 | protein antigen binding(GO:1990405) |
1.0 | 6.1 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
1.0 | 3.0 | GO:0023030 | MHC class Ib protein complex binding(GO:0023025) MHC class Ib protein binding, via antigen binding groove(GO:0023030) |
1.0 | 3.0 | GO:0008311 | double-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008311) |
1.0 | 2.9 | GO:0051734 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
1.0 | 2.9 | GO:0052854 | very-long-chain-(S)-2-hydroxy-acid oxidase activity(GO:0052852) long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity(GO:0052853) medium-chain-(S)-2-hydroxy-acid oxidase activity(GO:0052854) |
0.9 | 3.8 | GO:0002046 | opsin binding(GO:0002046) |
0.9 | 2.8 | GO:0052591 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
0.9 | 4.6 | GO:0016726 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
0.9 | 2.7 | GO:0004478 | methionine adenosyltransferase activity(GO:0004478) |
0.9 | 2.7 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.9 | 3.5 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.9 | 6.1 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.9 | 2.6 | GO:0004956 | prostaglandin D receptor activity(GO:0004956) |
0.9 | 2.6 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.9 | 7.7 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.9 | 5.1 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.8 | 2.5 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.8 | 2.5 | GO:0047025 | 3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity(GO:0047025) |
0.8 | 4.2 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.8 | 4.1 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.8 | 3.2 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.8 | 8.1 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.8 | 4.0 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.8 | 3.9 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.8 | 3.1 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.8 | 3.1 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.8 | 6.1 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.7 | 3.7 | GO:0042731 | PH domain binding(GO:0042731) |
0.7 | 2.9 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.7 | 3.7 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.7 | 4.4 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.7 | 3.6 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.7 | 13.0 | GO:0023023 | MHC protein complex binding(GO:0023023) |
0.7 | 13.8 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.7 | 2.1 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.7 | 9.8 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.7 | 2.1 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.7 | 12.5 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.7 | 3.4 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.7 | 2.0 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.7 | 3.3 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.7 | 41.5 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.7 | 5.9 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.6 | 0.6 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.6 | 3.2 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
0.6 | 20.9 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.6 | 3.2 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.6 | 124.5 | GO:0042393 | histone binding(GO:0042393) |
0.6 | 15.0 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.6 | 0.6 | GO:0000991 | transcription factor activity, core RNA polymerase II binding(GO:0000991) |
0.6 | 1.8 | GO:0034057 | RNA strand-exchange activity(GO:0034057) |
0.6 | 7.2 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.6 | 1.8 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.6 | 3.0 | GO:0036033 | mediator complex binding(GO:0036033) chromo shadow domain binding(GO:0070087) |
0.6 | 4.7 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.6 | 7.5 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.6 | 2.3 | GO:0035673 | lipid-transporting ATPase activity(GO:0034040) oligopeptide transmembrane transporter activity(GO:0035673) |
0.6 | 5.7 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.6 | 2.2 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.6 | 1.7 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
0.6 | 2.2 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.6 | 5.0 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.5 | 4.9 | GO:0015232 | heme transporter activity(GO:0015232) |
0.5 | 12.7 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.5 | 3.2 | GO:0000150 | recombinase activity(GO:0000150) |
0.5 | 11.5 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.5 | 1.6 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.5 | 1.6 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.5 | 1.5 | GO:0019809 | spermidine binding(GO:0019809) |
0.5 | 9.2 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.5 | 3.6 | GO:0005113 | patched binding(GO:0005113) |
0.5 | 1.5 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
0.5 | 1.0 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.5 | 3.6 | GO:0050700 | CARD domain binding(GO:0050700) |
0.5 | 4.0 | GO:0055104 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
0.5 | 1.5 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.5 | 4.5 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.5 | 1.0 | GO:0031720 | haptoglobin binding(GO:0031720) |
0.5 | 1.5 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.5 | 8.4 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.5 | 2.4 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.5 | 2.4 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.5 | 15.8 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.5 | 11.9 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.5 | 4.3 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.5 | 6.1 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.5 | 3.3 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.5 | 3.7 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.5 | 11.1 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.5 | 7.4 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.5 | 4.1 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.5 | 3.7 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.5 | 3.6 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.5 | 1.8 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.5 | 5.0 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.5 | 5.0 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.4 | 3.1 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.4 | 8.9 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.4 | 13.3 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.4 | 1.3 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
0.4 | 5.2 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.4 | 4.4 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.4 | 9.0 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.4 | 3.0 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.4 | 1.3 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.4 | 13.9 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.4 | 1.3 | GO:0005128 | erythropoietin receptor binding(GO:0005128) interleukin-3 receptor binding(GO:0005135) |
0.4 | 1.7 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.4 | 2.1 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.4 | 7.4 | GO:0070840 | dynein complex binding(GO:0070840) |
0.4 | 233.4 | GO:0046982 | protein heterodimerization activity(GO:0046982) |
0.4 | 1.6 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.4 | 1.6 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
0.4 | 6.0 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.4 | 8.0 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.4 | 34.6 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.4 | 5.2 | GO:0031491 | nucleosome binding(GO:0031491) |
0.4 | 19.1 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.4 | 1.2 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.4 | 1.6 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.4 | 1.2 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.4 | 12.5 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.4 | 5.8 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.4 | 10.0 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.4 | 3.0 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.4 | 11.8 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.4 | 0.7 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.4 | 1.4 | GO:0019863 | IgE receptor activity(GO:0019767) IgE binding(GO:0019863) |
0.3 | 2.1 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.3 | 3.8 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.3 | 2.1 | GO:0080084 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) 5S rDNA binding(GO:0080084) |
0.3 | 16.5 | GO:0016279 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.3 | 1.7 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.3 | 4.1 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.3 | 3.1 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.3 | 24.2 | GO:0004386 | helicase activity(GO:0004386) |
0.3 | 0.7 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.3 | 7.4 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.3 | 6.1 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.3 | 4.7 | GO:0033691 | sialic acid binding(GO:0033691) |
0.3 | 2.0 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.3 | 2.6 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.3 | 4.5 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.3 | 3.2 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.3 | 1.3 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.3 | 5.4 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.3 | 1.3 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.3 | 1.2 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.3 | 9.2 | GO:0050699 | WW domain binding(GO:0050699) |
0.3 | 1.5 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.3 | 3.9 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.3 | 6.2 | GO:0030515 | snoRNA binding(GO:0030515) |
0.3 | 4.4 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.3 | 1.2 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.3 | 10.1 | GO:0019843 | rRNA binding(GO:0019843) |
0.3 | 13.1 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.3 | 1.1 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.3 | 0.8 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) |
0.3 | 2.0 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.3 | 1.7 | GO:0086059 | voltage-gated calcium channel activity involved SA node cell action potential(GO:0086059) |
0.3 | 1.6 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.3 | 4.8 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.3 | 2.4 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.3 | 0.8 | GO:0031489 | myosin V binding(GO:0031489) |
0.3 | 1.6 | GO:0017040 | ceramidase activity(GO:0017040) |
0.3 | 1.1 | GO:0070513 | death domain binding(GO:0070513) |
0.3 | 4.5 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.3 | 3.1 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.3 | 20.8 | GO:0001047 | core promoter binding(GO:0001047) |
0.3 | 7.8 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.3 | 15.5 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.3 | 0.5 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.3 | 1.3 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.3 | 2.8 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.2 | 5.5 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.2 | 2.5 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.2 | 1.7 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.2 | 11.7 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.2 | 1.7 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.2 | 5.4 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.2 | 1.9 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.2 | 1.0 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.2 | 53.0 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.2 | 10.2 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.2 | 0.7 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.2 | 5.9 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.2 | 2.1 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.2 | 6.8 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
0.2 | 2.6 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.2 | 2.1 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.2 | 2.1 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.2 | 6.8 | GO:0030506 | ankyrin binding(GO:0030506) |
0.2 | 3.4 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.2 | 1.5 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.2 | 11.5 | GO:0030276 | clathrin binding(GO:0030276) |
0.2 | 3.3 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.2 | 45.1 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.2 | 1.5 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.2 | 0.8 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.2 | 3.4 | GO:0004518 | nuclease activity(GO:0004518) |
0.2 | 5.1 | GO:0015149 | hexose transmembrane transporter activity(GO:0015149) |
0.2 | 1.5 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.2 | 2.1 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.2 | 0.8 | GO:0030613 | oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor(GO:0016672) oxidoreductase activity, acting on phosphorus or arsenic in donors(GO:0030613) oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor(GO:0030614) glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
0.2 | 3.1 | GO:0015926 | glucosidase activity(GO:0015926) |
0.2 | 0.8 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.2 | 0.6 | GO:0008254 | 3'-nucleotidase activity(GO:0008254) |
0.2 | 3.7 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.2 | 2.2 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.2 | 9.1 | GO:0043022 | ribosome binding(GO:0043022) |
0.2 | 1.2 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.2 | 0.6 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.2 | 2.7 | GO:0070628 | proteasome binding(GO:0070628) |
0.2 | 0.7 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.2 | 39.1 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.2 | 2.6 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.2 | 0.5 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.2 | 2.6 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.2 | 0.7 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.2 | 1.0 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.2 | 0.7 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.2 | 1.0 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.2 | 1.3 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.2 | 0.6 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.2 | 2.2 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.2 | 8.5 | GO:0004527 | exonuclease activity(GO:0004527) |
0.2 | 4.4 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.1 | 1.5 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.1 | 1.5 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.1 | 0.9 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 1.2 | GO:0015925 | galactosidase activity(GO:0015925) |
0.1 | 9.9 | GO:0000989 | transcription factor activity, transcription factor binding(GO:0000989) |
0.1 | 2.0 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 1.2 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.1 | 1.0 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) |
0.1 | 1.1 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 1.2 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.1 | 2.3 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 0.4 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.1 | 15.9 | GO:0003682 | chromatin binding(GO:0003682) |
0.1 | 2.2 | GO:0071617 | lysophospholipid acyltransferase activity(GO:0071617) |
0.1 | 1.5 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.1 | 9.1 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.1 | 4.4 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.1 | 0.5 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.1 | 3.7 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 1.5 | GO:0008061 | chitin binding(GO:0008061) |
0.1 | 9.2 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 0.5 | GO:0004452 | isopentenyl-diphosphate delta-isomerase activity(GO:0004452) |
0.1 | 0.3 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.1 | 3.0 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 3.4 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.1 | 1.7 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 1.2 | GO:0048185 | activin binding(GO:0048185) |
0.1 | 2.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 24.8 | GO:0000976 | transcription regulatory region sequence-specific DNA binding(GO:0000976) |
0.1 | 3.2 | GO:0000049 | tRNA binding(GO:0000049) |
0.1 | 0.3 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 1.3 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 1.7 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 0.4 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 0.5 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.1 | 1.3 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.1 | 0.9 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 0.3 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.1 | 1.1 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.1 | 1.9 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.1 | 0.3 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
0.1 | 1.7 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 1.5 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.1 | 0.2 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) |
0.1 | 0.4 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.1 | 1.0 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 0.3 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.1 | 0.4 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 0.7 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.1 | 0.4 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.1 | 1.4 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.1 | 0.9 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.1 | 3.1 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 0.6 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 3.5 | GO:0004553 | hydrolase activity, hydrolyzing O-glycosyl compounds(GO:0004553) |
0.1 | 0.2 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.1 | 19.7 | GO:0005525 | GTP binding(GO:0005525) |
0.1 | 0.6 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 0.9 | GO:0016594 | glycine binding(GO:0016594) |
0.1 | 3.0 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.0 | 2.3 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.0 | 0.3 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.0 | 0.1 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.0 | 0.9 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
0.0 | 81.5 | GO:0003676 | nucleic acid binding(GO:0003676) |
0.0 | 1.0 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.2 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.0 | 0.3 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 0.1 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.0 | 0.9 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.3 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.0 | 1.0 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.0 | 0.2 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.0 | 0.2 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.0 | 0.7 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 0.1 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.1 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 1.6 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 86.0 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
1.4 | 49.4 | PID AURORA A PATHWAY | Aurora A signaling |
1.2 | 7.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
1.0 | 13.4 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
1.0 | 27.0 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
1.0 | 65.5 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.9 | 6.4 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.8 | 24.4 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.8 | 41.8 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.7 | 1.5 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.7 | 10.9 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.7 | 2.8 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.7 | 25.1 | PID AURORA B PATHWAY | Aurora B signaling |
0.6 | 24.5 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.6 | 6.4 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.6 | 5.8 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.6 | 36.1 | PID E2F PATHWAY | E2F transcription factor network |
0.6 | 11.8 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.6 | 24.3 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.5 | 8.2 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.5 | 6.3 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.5 | 7.1 | PID BARD1 PATHWAY | BARD1 signaling events |
0.5 | 17.4 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.5 | 7.9 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.5 | 5.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.5 | 16.2 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.5 | 10.9 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.4 | 1.8 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.4 | 14.3 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.4 | 10.6 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.4 | 3.2 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.4 | 5.0 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.4 | 17.1 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.3 | 12.2 | PID RHOA PATHWAY | RhoA signaling pathway |
0.3 | 5.8 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.3 | 2.6 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.3 | 5.3 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.3 | 10.1 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.2 | 0.7 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.2 | 4.6 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.2 | 3.1 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.2 | 4.2 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.2 | 2.3 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.2 | 2.3 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.2 | 5.7 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.2 | 3.2 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.2 | 4.5 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.2 | 1.5 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.2 | 4.4 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.2 | 3.3 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.2 | 5.8 | PID PLK1 PATHWAY | PLK1 signaling events |
0.2 | 2.8 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.2 | 3.9 | PID INSULIN PATHWAY | Insulin Pathway |
0.2 | 2.2 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.2 | 2.6 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 2.1 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 1.6 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 3.4 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.1 | 2.7 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 1.8 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 1.1 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 4.8 | PID P73PATHWAY | p73 transcription factor network |
0.1 | 0.7 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 1.5 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 2.1 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 1.9 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 3.8 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 3.2 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.1 | 0.9 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 1.4 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 1.2 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 1.7 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 0.6 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 0.7 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 0.6 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.0 | 4.2 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 0.6 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 0.9 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.3 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 0.5 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 1.0 | PID P53 REGULATION PATHWAY | p53 pathway |
0.0 | 0.3 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 1.0 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.9 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.8 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.4 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.0 | 0.4 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.6 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 0.3 | PID ARF6 PATHWAY | Arf6 signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.3 | 138.4 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
4.5 | 22.4 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
4.3 | 47.2 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
3.2 | 22.1 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
2.6 | 20.8 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
2.2 | 26.3 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
2.2 | 58.3 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
2.0 | 4.1 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
2.0 | 47.1 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
1.8 | 21.3 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
1.7 | 19.2 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
1.7 | 29.6 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
1.6 | 70.6 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
1.1 | 14.8 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
1.1 | 3.2 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
1.1 | 14.9 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
1.0 | 11.1 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.9 | 12.1 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.9 | 6.4 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.9 | 17.0 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.9 | 9.6 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.9 | 14.8 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.7 | 3.7 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.7 | 11.0 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.7 | 2.9 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.7 | 14.3 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.7 | 4.0 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.6 | 63.3 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.6 | 49.3 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.6 | 16.3 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.6 | 5.0 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.6 | 4.8 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.6 | 8.9 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.6 | 8.8 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.6 | 5.3 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.6 | 13.1 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.6 | 3.4 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.6 | 7.8 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.6 | 5.0 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.5 | 9.2 | REACTOME BASE EXCISION REPAIR | Genes involved in Base Excision Repair |
0.5 | 8.6 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.5 | 8.1 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.5 | 2.1 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.5 | 9.9 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.5 | 8.8 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.5 | 8.8 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.5 | 10.3 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.5 | 15.4 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.5 | 9.4 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.5 | 4.8 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.5 | 11.9 | REACTOME KINESINS | Genes involved in Kinesins |
0.5 | 13.0 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.4 | 5.0 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.4 | 2.9 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.4 | 6.8 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.4 | 1.8 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.4 | 4.7 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.3 | 6.3 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.3 | 3.3 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.3 | 8.2 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.3 | 2.6 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.3 | 4.0 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.3 | 30.6 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.3 | 4.7 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.3 | 7.6 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.3 | 5.5 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.3 | 19.7 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.3 | 4.5 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.3 | 5.0 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.3 | 6.6 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.3 | 5.4 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.3 | 15.6 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.3 | 2.9 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.3 | 0.8 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.2 | 1.5 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.2 | 4.7 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.2 | 9.4 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.2 | 4.2 | REACTOME RNA POL II TRANSCRIPTION | Genes involved in RNA Polymerase II Transcription |
0.2 | 7.7 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.2 | 4.4 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.2 | 7.9 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.2 | 4.0 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.2 | 6.8 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.2 | 2.7 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.2 | 4.3 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.2 | 9.1 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.2 | 4.0 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.2 | 2.5 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.2 | 2.6 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.2 | 1.3 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.2 | 3.1 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.2 | 1.3 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.2 | 6.4 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.2 | 2.7 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.2 | 3.3 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.2 | 2.8 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 2.0 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.1 | 1.3 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.1 | 1.7 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 2.3 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 0.9 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 7.1 | REACTOME TRANSLATION | Genes involved in Translation |
0.1 | 1.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 0.1 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.1 | 5.2 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 1.4 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.1 | 0.6 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 8.1 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 3.4 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 3.4 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 0.7 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.1 | 2.8 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.1 | 1.2 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.1 | 0.8 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
0.1 | 0.4 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.1 | 0.3 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 1.1 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.5 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.0 | 1.4 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 0.5 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.0 | 2.2 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.0 | 1.9 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.0 | 0.8 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.0 | 1.0 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 0.8 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.0 | 1.2 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 0.4 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 0.4 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 0.1 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.0 | 0.2 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.0 | 0.2 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |